ECSA Scientific Day 2023

Session

Oral Presentations

23 Nov 2023, 09:10

RC 150 - AUDITORIUM (IARC)

4. Characterising pulmonary carcinoids through molecular analyses within the lungNENomics project

Alexandra Sexton Oates (IARC)

23/11/2023, 09:10

Oral (8 min)

Introduction

Pulmonary carcinoids are well differentiated low to intermediate grade lung neuroendocrine tumours (LNETs), that belong to the group of lung neuroendocrine neoplasms which also include highly aggressive lung neuroendocrine carcinomas (LNECs). Carcinoids are further divided into atypical and typical, based on mitotic count and presence of necrosis. Although pulmonary carcinoids...

15. Socioeconomic status and lung cancer incidence: An analysis of 19 prospective cohorts from 4 continents

Justina Onwuka (IARC)

23/11/2023, 09:22

Oral (8 min)

Background: In some settings, lung cancer incidence appears higher among disadvantaged groups. We analyzed the harmonized database of the Lung Cancer Cohort Consortium (LC3) to assess the relationship between socioeconomic status and lung cancer incidence across different world regions.
Methods: We analyzed 19 prospective cohorts from 16 countries in North America, Europe, Asia, and...

5. Socioeconomic position and risk of cervical cancer in the Nordic countries: results from the Nordic Occupational Cancer Study (NOCCA)

Marzieh Eslahi (International Agency for Research on Cancer, Lyon, France)

23/11/2023, 09:34

Oral (8 min)

Background: The Nordic countries have benefited from steep declines in cervical cancer incidence rates, as a consequence of the implementation of nationwide screening programmes. However, it is not clear whether all social groups have equally benefited from these preventive services. We provided an assessment of the magnitude and temporal trends of cervical cancer incidence by socioeconomic...

22. Preventable and treatable avoidable cancer deaths in 185 countries for 34 cancer sites

Oliver Langselius (IARC)

23/11/2023, 09:46

Oral (8 min)

Introduction: Disparities in cancer-specific incidence, mortality, and survival exist worldwide. Avoidable deaths have recently been used to estimate the burden of disease and as a measure of the inequality between countries.
Methods: Five-year net survival estimates were obtained from the SURVCAN-3 project and from a review of the literature for 34 cancer sites. Survival estimates...

26. Incidence of childhood cancer in Latin America and the Caribbean: coverage, patterns and time trends

Neimar De Paula Silva (CSU/IARC)

23/11/2023, 09:58

Oral (8 min)

Introduction: Global childhood cancer control requires high-quality information, which is lacking particularly in low- and middle-income countries.
Methods: We described geographical variations in the period 2001-2010 and incidence trends over the period 1993-2012 in the populations under the age of 20 years of the countries in Latin America and the Caribbean (LAC) using the database...